Couttenye MM - Search Results

1

Determination of ionized calcium: evaluation of sampling and storage procedures.

Couttenye MM, Jurgens A, Lamberts LV, Verpooten GA, D'Haese PC, De Broe ME. Couttenye MM, et al. Clin Chem. 1996 Mar;42(3):468-9. Clin Chem. 1996. PMID: 8598117 No abstract available.

2

Higher serum aluminium concentrations in iron-depleted dialysis patients.

Vanuytsel JL, D'Haese PC, Couttenye MM, De Broe ME. Vanuytsel JL, et al. Among authors: couttenye mm. Nephrol Dial Transplant. 1992;7(2):177. doi: 10.1093/oxfordjournals.ndt.a092099. Nephrol Dial Transplant. 1992. PMID: 1314984 No abstract available.

3

Pyruvate kinase deficiency and delayed clinical response to recombinant human erythropoietin treatment.

Zachée P, Staal GE, Rijksen G, De Bock R, Couttenye MM, De Broe ME. Zachée P, et al. Among authors: couttenye mm. Lancet. 1989 Jun 10;1(8650):1327-8. doi: 10.1016/s0140-6736(89)92718-9. Lancet. 1989. PMID: 2566852 No abstract available.

4

Acquired immunodeficiency syndrome mimicking Sjögren's syndrome and systemic lupus erythematosus.

de Clerck LS, Couttenye MM, de Broe ME, Stevens WJ. de Clerck LS, et al. Among authors: couttenye mm. Arthritis Rheum. 1988 Feb;31(2):272-5. doi: 10.1002/art.1780310216. Arthritis Rheum. 1988. PMID: 3348828

5

Functional acute renal failure in a patient with carcinoid syndrome.

Couttenye MM, Verpooten GA, Daelemans RA, De Broe ME. Couttenye MM, et al. Nephron. 1987;47(2):131-3. doi: 10.1159/000184475. Nephron. 1987. PMID: 3696318

6

Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serum.

Van Hoof VO, Martin M, Blockx P, Prove A, Van Oosterom A, Couttenye MM, De Broe ME, Lepoutre LG. Van Hoof VO, et al. Among authors: couttenye mm. Clin Chem. 1995 Jun;41(6 Pt 1):853-7. Clin Chem. 1995. PMID: 7768003

7

Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.

Zachée P, Ferrant A, Daelemans R, Coolen L, Goossens W, Lins RL, Couttenye M, De Broe ME, Boogaerts MA. Zachée P, et al. Nephron. 1993;65(2):288-93. doi: 10.1159/000187490. Nephron. 1993. PMID: 8247195 Clinical Trial.

8

New insights and strategies in the diagnosis and treatment of aluminium overload in dialysis patients.

De Broe ME, D'Haese PC, Couttenye MM, Van Landeghem GF, Lamberts LV. De Broe ME, et al. Among authors: couttenye mm. Nephrol Dial Transplant. 1993;8 Suppl 1:47-50. doi: 10.1093/ndt/8.supp1.47. Nephrol Dial Transplant. 1993. PMID: 8389021 No abstract available.

9

Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients.

Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME. Lefebure AF, et al. Among authors: couttenye mm. Vaccine. 1993;11(4):397-9. doi: 10.1016/0264-410x(93)90278-6. Vaccine. 1993. PMID: 8470423 Clinical Trial.

10

Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.

D'Haese PC, Couttenye MM, Goodman WG, Lemoniatou E, Digenis P, Sotornik I, Fagalde A, Barsoum RS, Lamberts LV, De Broe ME. D'Haese PC, et al. Among authors: couttenye mm. Nephrol Dial Transplant. 1995 Oct;10(10):1874-84. Nephrol Dial Transplant. 1995. PMID: 8592597 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters